Good Apple Delivers 3.6x Higher Qualified Patient Visit Rate with PulsePoint’s Innovative Adaptive Optimization™

Good Apple partnered with PulsePoint to improve audience quality and reduce wasted spend for a rare disease brand. Traditional DSPs built for general advertising often optimize toward proxy media signals, often missing clinically relevant patients. PulsePoint takes a different approach, using healthcare-specific data to drive meaningful outcomes.
‍
Good Apple leveraged PulsePoint’s Adaptive Optimization™, which uses real-time clinical data and digital signals to guide bidding and media delivery, to drive results for a rare disease brand. Instead of treating all impressions equally, Adaptive Optimization prioritizes audiences most likely to meet clinical targeting criteria, aligning media investment with real patient relevance.

Good Apple + PulsePoint worked together to ensure 83% of spend was concentrated on highest-value audiences, which delivered:

• 2.6x higher Crossix targeting multiple
• 3.6x higher qualified patient visit rate

Compared to another DTC DSP, PulsePoint delivered significantly stronger efficiency and audience precision which is critical for rare disease campaigns where every impression counts and waste is not tolerated.
‍
By optimizing toward clinical outcomes, not just media signals, PulsePoint helps brands reach the right patients, reduce waste, and drive measurable performance.
‍
“PulsePoint consistently delivers high engagement and Cost Per Qualified Visit. With Adaptive Optimization, we can drive breakthrough performance for DTC campaigns.”
— George Tarnopolsky, VP Programmatic, Good Apple

Download the Full Case Study -->